CLINICAL_TRIALS
trial_result
· 2017-03-30
Clinical Trial Update: Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease [NA]
Summary
Romidepsin was evaluated in patients with steroid-refractory graft-versus-host disease; the trial was terminated and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rutgers, The State University of New Jersey | Conditions: Graft Versus Host Disease | NA | Status: TERMINATED | Results posted: 2017-03-30